Expert Opinion on Emerging Drugs

*Expert Opinion on Emerging Drugs*
Discipline	Pharmacology
Language	English
Edited by	Claire Attwood
Publication details
Former name(s)	Emerging Drugs
History	1996–present
Publisher	Informa
Frequency	Quarterly
Impact factor	3.912 (2021)
Standard abbreviations;
ISO 4	Expert Opin. Emerg. Drugs
Indexing;
ISSN	1472-8214 (print); 1744-7623 (web);
Links
	Journal homepage;

Expert Opinion on Emerging Drugs is a quarterly peer-reviewed medical journal publishing structured reviews on drugs/drug classes emerging onto the market across all therapy areas. Each review includes an "expert opinion" section, in which authors are asked to provide their personal view on the current status and future direction of the research discussed. It was established as Emerging Drugs in 1996, changing to its current name in 2001. It is published by Taylor & Francis. In 2021 the journal stated that it had an impact factor of 3.912.^[1]

References

^ From journal Web site

External links

Official website

This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it.

See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.

[1] From journal Web site

[1]